Antigenic composition comprising an HIV gag or env polypeptide

Details Antigenic composition comprising an HIV gag or env polypeptide Antigenic composition comprising an HIV gag or env polypeptide

2007-10-23

2007-10-23

Zeman, Mary K. (Department: 1631)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S188100, C424S185100, C424S204100, C424S207100, C424S208100, C435S005000, C435S007100, C435S974000, C514S002600

Reexamination Certificate

active

08456024

ABSTRACT:
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome, for expression of polypeptides and use of the polypeptides to prepare antibodies, where both the polypeptides and antibodies may be employed as diagnostic reagents or in therapy, e.g., vaccines and passive immunization. The sequences provide detection of the viral infectious agents associated with the indicated syndromes and can be used for expression of antigenic polypeptides.

REFERENCES:
patent: 4520113 (1985-05-01), Gallo
patent: 4629783 (1986-12-01), Cosand
patent: 4708818 (1987-11-01), Montagnier
patent: 4716102 (1987-12-01), Levy
patent: 35 87 394 (1993-06-01), None
patent: 0 020 251 (1980-12-01), None
patent: 0 060 057 (1982-09-01), None
patent: 0 062 574 (1982-10-01), None
patent: 0 073 635 (1983-03-01), None
patent: 0 088 632 (1983-09-01), None
patent: 0 116 201 (1984-08-01), None
patent: 0 136 798 (1985-04-01), None
patent: 0 138 667 (1985-04-01), None
patent: 0 139 216 (1985-05-01), None
patent: 0 152 030 (1985-08-01), None
patent: 0 165 120 (1985-12-01), None
patent: 0 173 529 (1986-03-01), None
patent: 0 178 978 (1986-04-01), None
patent: 0 181 150 (1986-05-01), None
patent: 0 181 150 (1986-05-01), None
patent: 0 185 444 (1986-06-01), None
patent: 0 187 041 (1986-07-01), None
patent: 0 201 540 (1986-11-01), None
patent: 0 178 978 (1992-02-01), None
patent: 2104902 (1983-03-01), None
patent: 84/23659 (1984-09-01), None
patent: 84/16013 (1984-10-01), None
patent: 84/29099 (1984-11-01), None
patent: 85/01473 (1985-01-01), None
patent: 85/04897 (1985-11-01), None
patent: 85/04903 (1985-11-01), None
patent: 86/02383 (1986-04-01), None
patent: 86/06414 (1986-11-01), None
Chang et al 1985. Science vol. 228 p. 93, Apr. 5, 1985.
Sanchez-Pescador et al. 1985. Science vol. 227 p. 484, Feb. 1, 1985.
Arthur et al 1989. J. Virology vol. 63 p. 5046, Dec. 1989.
Bolognesi 1990. Mol Biol Med. vol. 7 p. 1, Apr. 1990.
Roitt and Delves Eds. Encyclopedia of Immunology, Harcourt Brace Jovanovich, London, p. 813, Nov. 19, 1993.
U.S. Appl. No. 06/728,052, filed Apr. 29, 1985, Cosand.
U.S. Appl. No. 06/767,303, filed Aug. 19, 1985, Cosand.
U.S. Appl. No. 06/685,272, filed Dec. 24, 1984, Capon.
U.S. Appl. No. 06/844,485, filed Mar. 26, 1986, Cosand.
Allan et al.,Science(1985) 228:1091-1094.
Amann et al.,Gene(1983) 25:167-178.
Barin et al.,Science(1985) 228:1094-1096.
Beardsley et al.,Nature(1984) 311:195.
Bolivar et al.,Gene(1977) 2:95-113.
Brun-Vezinet et al.,Lancet(1984) 1253-1256.
Casadban et al.,J. Bacteriology(1980) 143(2) :971-980.
Chanda et al.,FASEB Proceedings(1985) 44(5) :1540.
Chang et al.,J. Cell Biochem.(1985) 9A: 81 Abstract 0187.
Chang et al.,Science(1985) 228:93-96.
Chang et al.,Nature(1985) 315:151-154.
Chang et al.,Bio/Technology(1985) 3(10) :905-909.
Chemical and Engineering News, (1984) p. 7.
Chen et al.,Nature(1984) 309:276-279.
Chen et al.,Nature(1983) 305:502-505.
Chermann et al., in Gottlieb et al. (eds. 1984) “Acquired Immune Deficiency Syndrome”UCLA Symposia on Molecular Biology, News Series, vol. 16 (1984) pp. 31-46.
Clinica,Abstract(1984) p. 9.
De Boer et al.,Proc. Natl. Acad. Sci.(1983) 80:21-25.
DiMaio et al.,Proc. Natl. Acad. Sci.(1982) 79:4030-4032.
Dina et al.,DNA(1985) 4(1):56.
Ellrodt et al.,Lancet(1984) 1:1383-1385.
Fisher et al.,Nature(1985) 316:262-265.
Fischinger et al.,Cancer Research(1985) 45:4694s-4699s.
Translation of Action for Grant of Compulsory License to EP 0 181 150, Jul. 3, 2000.
Interlocutory Decision in Opposition Proceedings 85 307 860.8, Mar. 10, 1998 (English translation, Exhibit K2 filed in compulsory license action [D3]).
Interlocutory Decision in Opposition Proceedings 85 307 860.8, Mar. 10, 1998 (original German, Exhibit K2a filed in compulsory license action [D3]).
Minutes of Oral Proceedings in T351/98-334, Nov. 2, 3, and 4, 1999 (Exhibit K4 filed in compulsory license action [D3]).
Copy from Römpp's Lexikon der Chemie, 10thed., Stuttgart/New York, 1999 (Exhibit K6 in compulsory license action [D3]).
Copy from Römpp's Lexikon der Biotechnologie und Gentechnik, 2d ed., Stuttgart/New York, 1999 (Exhibit K7 filed in compulsory license action [D3]).
Product description of Amplicor HIV-1 Monitor™ Test, Version 1.5, Nov. 1998 (Exhibit K8 filed in compulsory license action [D3]).
Product description of COBAS HIV-1 Monitor™ Test, version 1.5, May 1999 (Exhibit K9 filed in compulsory license action [D3]).
Roland et al., Pitfalls of HIV RNA testing in the San Francisco Post-Exposure Prevention Project, presented at the 6thConference on retroviruses and Opportunistic Infections (Chicago, Feb. 1999) (Exhibit K13 filed in compulsory license action[D3]).
Perez et al., Evaluation of the New Quantiplex 3.0 HIV bDNA Asay (Q3): A comparison with Quantiplex 2.0 (Q2), presented at the 6thConference on retroviruses and Opportunistic Infections (Chicago, Feb. 1999) (Exhibit K14 filed in compulsory license action [D3]).
Decision of the 4thDivision for Civil Matters of the Regional Court Düsseldorf pronounced May 18, 2000 (original German, Exhibit K15 filed in compulsory license action [D3]).
Decision of the 4thDivision for Civil Matters of the Regional Court Düsseldorf pronounced May 18, 2000 (English translation of Exhibit K15 filed in compulsory license action [D3]).
Letter to William Green, Chiron Corporation, dated Jun. 2, 1999 (Exhibit K16 filed in compulsory license action [D3]).
Letter to William Green, Chiron Corporation, dated May 19, 2000 (Exhibit K17 filed in compulsory license action [D3]).
HIV/AIDS/STI Surveillance, http://www.who.int/health.topics/hiv.htm, '00 (Exhibit K18 filed in compulsory license action [D3]).
Allgemeines zu den epidemiologischen Seiten über HIV/AIDS, Robert Koch-Institut, 1999 (Exhibit K19 filed in compulsory license action [D3]).
Remarks as prepared for delivery by Vice President Al Gore, United Nations Security Council Opening Session, Jan. 10, 2000 (Exhibit K20 filed in compulsory licencse action [D3]).
Statement by Dr. Andreas Plettenberg, HAART 1998—Möglichkeiten und Grenzen, 1998 (Exhibit K21 filed in compulsory license action [D3]).
Declaration by the joint practice of Dr. med. Knechten, Dr. med Habetz dated Jun. 5, 2000 (Exhibit K24 filed in compulsory license action [D3]).
Declaration of Michael P. Dooley, Oct. 3, 1991, filed in Chiron Corporation v. Roche Nederland B.V. et al., Case No. 98/870.
Declaration of Joseph M. Perillo, 1999, filed in Chiron Corporation v. F. Hoffmann-La Roche AG et al., Case No. 7 0 21945/97.
Statement of Claim dated Nov. 27, 1997, Certified Copy of Court Directions dated Dec. 3, 1997, and copy of decision dated Dec. 3, 1997 in Case No. 7 0 21945/97 (Action for a Negative Declaration).
Decision on Preliminary Motions, Interference No. 105,291, Sep. 1, 2006.
Decision on Preliminary Motions, Interference No. 105,289, Sep. 1, 2006.
French, T.J.,First Declaration of T.J. French(1994).
Gallo et al., in Gottlieb et al. Eds. (1984) pp. 47-58 “Acquired Immune Deficiency Syndrome”UCLA Symposia on Molecular Biology, New Series (1984) 16:47-58.
Gluzman e tal.,Cell(1981) 23:175-182.
Gnann et al.,J. Virology(1987) 61(8):2639-2641.
Gray et al.,Proc. Natl. Acad. Sci.(1982) 79:6598-6602.
Groopman et al.,New Eng. J. Med.(1984) 311(22):1419-1422.
Hahn et al.,Nature(1984) 312:166-169.
Hattori et al.,Virology(1984) 136:338-347.
Huang et al.,DNA(1985) 4(1):70.
Karn et al.,Meth. Enzymology(1983) 101:3-19.
Kitchen et al.,Nature(1984) 312:367-369.
Kiyokawa et al.,Proc. Natl. Acad. Sci.(1984) 81:6202-6206.
Levy et al.,Ann. Int. Med.(1985) 103:694-699.
Liou et la.,DNA(1985) 4(1):71.
Luciw et al.,DNA(1985) 4(1):71.
Maniatis et al.,Cold Spring Harbor Laboratory“Molecular Cloning” (1982) pp. 406-427.
Maxam et al.,Methods Enzymol.(1980) 65:499-560.
Mellon et al.,Cell(1981) 27:279-288.
Montagnier et al.,Ann. Virol.(1984) 135E:119-134.
Montagnier et al.,Virology(1985) 144:283-289.
Montagnier et al., in Retroviruses in Human Lymp

Affiliated with

Also associated with

Rating

Antigenic composition comprising an HIV gag or env polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigenic composition comprising an HIV gag or env polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic composition comprising an HIV gag or env polypeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3885569